Role of glutaredoxin-mediated protein S-glutathionylation in cellular nitroglycerin tolerance

Journal of Pharmacology and Experimental Therapeutics

Volumn 329, Issue 2, 2009, Pages 649-656

  Tsou, Pei Suen ^a   Addanki, Vamsi ^a   Haas, Jessica A ^a   Page, Nathaniel A ^a   Fung, Ho Leung ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ASCORBIC ACID; CREATINE KINASE; CYCLIC GMP; GLUTAREDOXIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCERYL TRINITRATE; PROTEIN P21; SUPEROXIDE; THIOL DERIVATIVE; XANTHINE OXIDASE; HRAS PROTEIN, HUMAN; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG TOLERANCE; ENDOTHELIUM CELL; ENZYME ACTIVITY; EX VIVO STUDY; IN VIVO STUDY; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SWINE; THORACIC AORTA; VASODILATATION; WESTERN BLOTTING;

ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CREATINE KINASE; CYCLIC GMP; DRUG TOLERANCE; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTAREDOXINS; GLUTATHIONE; HUMANS; LLC-PK1 CELLS; NITROGLYCERIN; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS; SWINE; TRANSFECTION; VASODILATION; VASODILATOR AGENTS;

EID: 65649120701     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.149997     Document Type: Article

References (39)

1. Adachi T, Pimentel DR, Heibeck T, Hou X, Lee YJ, Jiang B, Ido Y, and Cohen RA (2004) S-Glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem 279:29857-29862.
2. Ayala-Fierro F and Carter DE (2000) LLC-PK1 cells as a model for renal toxicity caused by arsine exposure. J Toxicol Environ Health A 60:67-79.
3. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, and Murphy MP (2004) Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 279:47939-47951.
4. Bennett BM, Leitman DC, Schröder H, Kawamoto JH, Nakatsu K, and Murad F (1989) Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines. J Pharmacol Exp Ther 250:316-323.
5. Beretta M, Gruber K, Kollau A, Russwurm M, Koesling D, Goessler W, Keung WM, Schmidt K, and Mayer B (2008) Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases. J Biol Chem 283:17873-17880.
6. Bertrand L, Horman S, Beauloye C, and Vanoverschelde JL (2008) Insulin signalling in the heart. Cardiovasc Res 79:238-248.
7. Boesgaard S, Aldershvile J, Poulsen HE, Loft S, Anderson ME, and Meister A (1994) Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ Res 74:115-120.
8. Borges F, Fernandes E, and Roleira F (2002) Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 9:195-217.
9. Braughler JM (1983) Soluble guanylate cyclase activation by nitric oxide and its reversal. Involvement of sulfhydryl group oxidation and reduction. Biochem Pharmacol 32:811-818.
10. Chen Z, Zhang J, and Stamler JS (2002) Identification of the enzymatic mechanism of nitroglycerin bio activation. Proc Natl Acad Sci USA 99:8306-8311.
11. Chong S and Fung HL (1989) Kinetic mechanisms for the concentration dependency of in vitro degradation of nitroglycerin and glyceryl dinitrates in human blood: metabolite inhibition or cosubstrate depletion? J Pharm Sci 78:295-302.
12. Clavreul N, Adachi T, Pimental DR, Ido Y, Schöneich C, and Cohen RA (2006a) S-Glutathiolation by peroxynitrite of p2lras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J 20:518-520.
13. Clavreul N, Bachschmid MM, Hou X, Shi C, Idrizovic A, Ido Y, Pimentel D, and Cohen RA (2006b) S-Glutathiolation of p2lras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler Thromb Vase Biol 26:2454-2461.
14. 2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 271:14169-14175.
15. Fernandes AP and Holmgren A (2004) Glutaredoxins: glut athione-dep en dent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6:63-74.
16. Fink B, Schwemmer M, Fink N, and Bassenge E (1999) Tolerance to nitrates with enhanced radical formation suppressed by carvedilol. J Cardiovasc Pharmacol 34:800-805.
17. Fung HL (2004) Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved? Annu Rev Pharmacol Toxicol 44:67-85.
18. Giustarini D, Rossi R, Milzani A, Colombo R, and Dalle-Donne I (2004) S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 8:201-212.
19. Griffith OW and Meister A (1979) Glutathione: interorgan translocation, turnover, and metabolism. Proc Natl Acad Sci U S A 76:5606-5610.
20. Hinz B and Schroder H (1998) Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis. Biochem Biophys Res Commun 252:232-235.
21. Hinz B and Schroder H (1999) The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells. Pharm Res 16:633-636.
22. Jones DP, Moldfus P, Stead AH, Ormstad K, Jörnvall H, and Orrenius S (1979) Metabolism of glutathione and a glutathione conjugate by isolated kidney cells. J Biol Chem 254:2787-2792.
23. Klatt P and Lamas S (2000) Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 267:4928-4944.
24. Lee WI and Fung HL (2003) Mechanism-based partial inactivation of glutathione S-transferases by nitroglycerin: tyrosine nitration vs sulfhydryl oxidation. Nitric Oxide 8:103-110.
25. Mollnau H, Wendt M, Szòcs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, et al. (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58-E65.
26. Mülsch A, Oelze M, Klöss S, Mollnau H, Töpfer A, Smolenski A, Walter U, Stasch JP, Warnholtz A, Hink U, et al. (2001) Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation 103:2188-2194.
27. Münzel T, Daiber A, and Mülsch A (2005) Explaining the phenomenon of nitrate tolerance. Circ Res 97:618-628.
28. Münzel T, Sayegh H, Freeman BA, Tarpey MM, and Harrison DG (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95:187-194.
29. Muslin AJ (2008) MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond) 115:203-218.
30. Needleman P and Johnson EM Jr (1973) Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184:709-715.
31. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, and Yushak M (1987) Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 317:799-804.
32. Rabito CA, Kreisberg JI, and Wight D (1984) Alkaline phosphatase and gamma-glutamyl transpeptidase as polarization markers during the organization of LLC-PK1 cells into an epithelial membrane. J Biol Chem 259:574-582.
33. Shelton MD, Chock PB, and Mieyal JJ (2005) Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 7:348-366.
34. Tate SS, Grau EM, and Meister A (1979) Conversion of glutathione to glutathione disulfide by cell membrane-bound oxidase activity. Proc Natl Acad Sci U S A 76:2715-2719.
35. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, and Murphy MP (2003) Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278:19603-19610.
36. Tsou PS, Addanki V, and Fung HL (2008) Dissociation between superoxide accumulation and nitroglycerin-induced tolerance. J Pharmacol Exp Ther 327:97-104.
37. Wada A, Ueda S, Masumori-Maemoto S, Kuji N, Sugimoto K, and Umemura S (2002) Angiotensin II attenuates the vasodilating effect of a nitric oxide donor, glyceryl trinitrate: roles of superoxide and angiotensin II type 1 receptors. Clin Pharmacol Ther 71:440-447.
38. Waldman SA, Rapoport RM, Ginsburg R, and Murad F (1986) Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 35:3525-3531.
39. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Münzel T, et al. (2007) Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem 282:792-799.